This technology consists of a microdevice that separates blood cells based on differences in antigen expression. Cells of the same phenotype are separated based on their activation levels during infection and resting, thus enabling the microdevice to provide differential cell counts as a diagnostic tool for infections and inflammations.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Prototype
Technology Readiness Level: TRL 5
Organization Type: Early-stage Startup (Seed)
Market Keywords: early detection, point-of-care